Thus, we conclude that high expression of IL-17RB in CSCs promotes cancer initiation, propagation, metastasis, and recurrence, and IL-17B and IL-17RB form a positive feedback loop that further amplifies the IL-17B/IL-17RB signaling cascade in the tumor environment. Here, IL17RB is linked to cancer.